The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
A Quantitative, Risk-Based Approach to the Management of Neonatal Early-Onset Sepsis
Abstract
Importance: Current algorithms for management of neonatal early-onset sepsis (EOS) result in medical intervention for large numbers of uninfected infants. We developed multivariable prediction models for estimating the risk of EOS among late preterm and term infants based on objective data available at birth and the newborn's clinical status. Objectives: To examine the effect of neonatal EOS risk prediction models on sepsis evaluations and antibiotic use and assess their safety in a large integrated health care system. Design, Setting, and Participants: The study cohort includes 204 485 infants born at 35 weeks' gestation or later at a Kaiser Permanente Northern California hospital from January 1, 2010, through December 31, 2015. The study compared 3 periods when EOS management was based on (1) national recommended guidelines (baseline period [January 1, 2010, through November 31, 2012]), (2) multivariable estimates of sepsis risk at birth (learning period [December 1, 2012, through June 30, 2014]), and (3) the multivariable risk estimate combined with the infant's clinical condition in the first 24 hours after birth (EOS calculator period [July 1, 2014, through December 31, 2015]). Main Outcomes and Measures: The primary outcome was antibiotic administration in the first 24 hours. Secondary outcomes included blood culture use, antibiotic administration between 24 and 72 hours, clinical outcomes, and readmissions for EOS. Results: The study cohort included 204 485 infants born at 35 weeks' gestation or later: 95 343 in the baseline period (mean [SD] age, 39.4 [1.3] weeks; 46 651 male [51.0%]; 37 007 white, non-Hispanic [38.8%]), 52 881 in the learning period (mean [SD] age, 39.3 [1.3] weeks; 27 067 male [51.2%]; 20 175 white, non-Hispanic [38.2%]), and 56 261 in the EOS calculator period (mean [SD] age, 39.4 [1.3] weeks; 28 575 male [50.8%]; 20 484 white, non-Hispanic [36.4%]). In a comparison of the baseline period with the EOS calculator period, blood culture use decreased from 14.5% to 4.9% (adjusted difference, -7.7%; 95% CI, -13.1% to -2.4%). Empirical antibiotic administration in the first 24 hours decreased from 5.0% to 2.6% (adjusted difference, -1.8; 95% CI, -2.4% to -1.3%). No increase in antibiotic use occurred between 24 and 72 hours after birth; use decreased from 0.5% to 0.4% (adjusted difference, 0.0%; 95% CI, -0.1% to 0.2%). The incidence of culture-confirmed EOS was similar during the 3 periods (0.03% in the baseline period, 0.03% in the learning period, and 0.02% in the EOS calculator period). Readmissions for EOS (within 7 days of birth) were rare in all periods (5.2 per 100 000 births in the baseline period, 1.9 per 100 000 births in the learning period, and 5.3 per 100 000 births in the EOS calculator period) and did not differ statistically (P = .70). Incidence of adverse clinical outcomes, including need for inotropes, mechanical ventilation, meningitis, and death, was unchanged after introduction of the EOS calculator. Conclusions and Relevance: Clinical care algorithms based on individual infant estimates of EOS risk derived from a multivariable risk prediction model reduced the proportion of newborns undergoing laboratory testing and receiving empirical antibiotic treatment without apparent adverse effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Segmented regression analysis of interrupted time series studies in medication use research
Wagner, A. K., Soumerai, S. B., Zhang, F., & Ross-Degnan, D. (2002) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.2002.00430.x · Cited by 3,279
Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010.
Schrag, S. D., Gorwitz, R. J., Fultz-Butts, K., & Schuchat, A. (2002) · PubMed · Cited by 3,183
Big Data In Health Care: Using Analytics To Identify And Manage High-Risk And High-Cost Patients
Bates, D. W., Saria, S., Ohno-Machado, L., Shah, A., & Escobar, G. (2014) · Health Affairs · doi:10.1377/hlthaff.2014.0041 · Cited by 1,235
Self-citationEarly Onset Neonatal Sepsis: The Burden of Group B Streptococcal and E. coli Disease Continues
Stoll, B. J., Hansen, N. I., Sánchez, P. J., Faix, R. G., Poindexter, B. B., Van Meurs, K. P., Bizzarro, M. J., Goldberg, R. N., Frantz, I. D., Hale, E. C., et al. (2011) · Pediatrics · doi:10.1542/peds.2010-2217 · Cited by 1,077
Kontopantelis, E., Doran, T., Springate, D. A., Buchan, I., & Reeves, D. (2015) · BMJ · doi:10.1136/bmj.h2750 · Cited by 1,001
Early life antibiotic‐driven changes in microbiota enhance susceptibility to allergic asthma
Russell, S. L., Gold, M. J., Hartmann, M., Willing, B. P., Thorson, L., Wlodarska, M., Gill, N., Blanchet, M., Mohn, W. W., McNagny, K. M., et al. (2012) · The EMBO Reports · doi:10.1038/embor.2012.32 · Cited by 883
Epidemiology of Invasive Group B Streptococcal Disease in the United States, 1999-2005
Phares, C. R. (2008) · JAMA · doi:10.1001/jama.299.17.2056 · Cited by 878
Higgins, R. D., Saade, G., Polin, R. A., Grobman, W. A., Buhimschi, I. A., Watterberg, K., Silver, R. M., & Raju, T. N. K. (2016) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000001246 · Cited by 579
Ajslev, T. A., Andersen, C. S., Gamborg, M., Sørensen, T. I. A., & Jess, T. (2011) · International Journal of Obesity · doi:10.1038/ijo.2011.27 · Cited by 534
The Burden of Invasive Early-onset Neonatal Sepsis in the United States, 2005–2008
Weston, E. J., Pondo, T., Lewis, M. M., Martell-Cleary, P., Morin, C. A., Jewell, B., Kirley, P. D., Apostol, M. M., Petit, S., Farley, M. M., et al. (2011) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318223bad2 · Cited by 508
Cited by
Puopolo, K. M., Benitz, W. E., Zaoutis, T. E., COMMITTEE ON FETUS AND NEWBORN, COMMITTEE ON INFECTIOUS DISEASES, Cummings, J., Juul, S., Hand, I., Eichenwald, E., Poindexter, B., et al. (2018) · Pediatrics · doi:10.1542/peds.2018-2894 · Cited by 459
Self-citationCommittee Opinion No. 712: Intrapartum Management of Intraamniotic Infection
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002236 · Cited by 373
Management of Infants at Risk for Group B Streptococcal Disease
Puopolo, K. M., Lynfield, R., Cummings, J. J., COMMITTEE ON FETUS AND NEWBORN, COMMITTEE ON INFECTIOUS DISEASES, Hand, I., Adams-Chapman, I., Poindexter, B., Stewart, D. L., Aucott, S. W., et al. (2019) · Pediatrics · doi:10.1542/peds.2019-1881 · Cited by 317
Self-citationKlingenberg, C., Kornelisse, R. F., Buonocore, G., Maier, R. F., & Stocker, M. (2018) · Frontiers in Pediatrics · doi:10.3389/fped.2018.00285 · Cited by 292
Antibiotic stewardship in neonates: challenges and opportunities
Ting, J. Y., & Shah, P. S. (2020) · Translational Pediatrics · doi:10.21037/tp-20-134 · Cited by 15
Metadata
- Authors
- Kuzniewicz, M. W., Puopolo, K. M., Fischer, A., Walsh, E. M., Li, S., Newman, T. B., Kipnis, P., & Escobar, G. J.
- Venue
- JAMA Pediatrics
- Publisher
- American Medical Association (AMA)
- Published
- 2017-04-01
- Volume
- 171
- Issue
- 4
- Pages
- 365
- ISSN
- 1072-4710 (ISSN-L)
- 2168-6203
- OpenAlex
- W2593600449
- Cited by
- 464
- References
- 35
- FWCI
- 40.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Quantitative, Risk-Based Approach to the Management of Neonatal Early-Onset Sepsis. https://app.cochat.ai/papers/10.1001/jamapediatrics.2016.4678
- The paper
- Kuzniewicz, M. W., Puopolo, K. M., Fischer, A., Walsh, E. M., Li, S., Newman, T. B., Kipnis, P., & Escobar, G. J. (2017). A Quantitative, Risk-Based Approach to the Management of Neonatal Early-Onset Sepsis. JAMA Pediatrics. https://doi.org/10.1001/jamapediatrics.2016.4678
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.